Background {#Sec1}
==========

Intracranial hypertension is a deadly complication and one of the contributing factor in secondary brain injury because its intensity and duration are associated with a fatal outcome \[[@CR1]\].

Imaging modalities with clinical examination protocol have a lack of specificity \[[@CR2]\] and insufficient accuracy \[[@CR3]\]. Therefore, the invasive intracranial pressure measurement method is recommended \[[@CR4]\] but a multicenter, controlled trial on patients with brain injury comparing care focused on imaging and clinical examination with care focused on maintaining intracranial pressure at 20 mmHg or less has found no significant differences \[[@CR2]\].

The use of an intraventricular catheter/ intraparenchymal micro transducer may cause complications like infection or hemorrhage \[[@CR5]\]. Therefore, the invasive intracranial pressure measurement method is only used in severe traumatic brain injury when systemic complications are absent \[[@CR6]\]. When invasive intracranial pressure measurement method is contraindicated, imaging modalities with clinical examination would be preferred \[[@CR4]\]. A prospective, observational study on patients with traumatic brain injuries recommended ocular sonography as a screening test for raised intracranial pressure measurements \[[@CR7]\]. A retrospective study suggested transcranial Doppler for measurement of intracranial pressure \[[@CR8]\]. Two-depth transcranial Doppler has better diagnostic reliability for intracranial pressure measurements \[[@CR9], [@CR10]\].

The primary aim of the retrospective study was to compare the accuracy of diagnostic parameters of ultrasound measurements in patients with brain injury underwent invasive intracranial pressure measurement method. The secondary endpoint of the study was to evaluate independent diagnostic parameters for mortality of patients in a Chinese setting.

Methods {#Sec2}
=======

Inclusion criteria {#Sec3}
------------------

Patients age 18 years or older with severe traumatic brain injury, intraparenchymal hemorrhage, aneurysmal subarachnoid hemorrhage, or stroke (decision of neurosurgeon) were included in the analysis. Among these patients, who required sedation, intracranial pressure monitoring or mechanical ventilation with an admission diagnosis were included in the analysis.

Exclusion criteria {#Sec4}
------------------

Patients were excluded from the analysis who had optic nerve injuries, skull base fracture (with cerebrospinal fluid leaks), an ocular pathology, inaccessible ultrasound windows, and no radiological or clinical susceptibility of cerebral venous vasospasm or thrombosis. Patients whose intracranial pressure mean values changed \> 2 mmHg during ultrasound measurements and who had a history of glaucoma were not included in the analysis.

Clinical management of patients {#Sec5}
-------------------------------

Patients were put on propofol (a continuous infusion) and the muscle relaxant (atracurium) was given when necessary. Mechanical ventilation was adjusted to maintain normocapnia (partial pressure of carbon dioxide: 38 ± 2 mmHg) and adequate oxygenation (peripheral oxygen saturation ≥ 91%). The adequate cerebral perfusion pressure had been maintained ≥61 mmHg by norepinephrine, vasopressors, and normal saline \[[@CR11]\]. As per institutional guidelines, intracranial hypertension had been treated by optimizing arterial blood pressure and using hyperosmolar fluids and sedation infusion.

Invasive intracranial pressure measurement method {#Sec6}
-------------------------------------------------

Intracranial pressure had been measured by intensive care physician (minimum 10-years of experience) of institutes using 1.3 mm Tunnelling intraparenchymal probe (3PN, Spiegelberg GmbH & Co. KG, Hamburg, Germany) or a catheter inserted into the ventricles of brain and was connected to an external drainage and pressure transducer and system (Camino®, Integra® Life Sciences Corporation, Plainsboro, NJ, USA). Admission Glasgow Coma Scale, demographical characteristics, comorbidities, severity and mechanism of brain injuries, and discharge Glasgow Outcome Scale were recorded for each patient \[[@CR12]\].

Ultrasound measurements {#Sec7}
-----------------------

Ultrasound measurements had been performed by ultrasound equipment (GE Healthcare, Beijing, China) by ultra-sonographers of the institutes (blinded regarding the results of the invasive intracranial pressure measurement method and minimum 10-years of experience). The mean values of five individual measurements were considered in the analysis. Venous transcranial Doppler measurements, optic nerve sheath diameter, and arterial transcranial doppler had been measured twice in a day from day 1--5 at 50--80 mm optic nerve blood pressure (as accessible ultrasound windows).

Venous transcranial Doppler measurements {#Sec8}
----------------------------------------

Arterial blood pressure, cerebral perfusion pressure, the partial pressure of carbon dioxide, diastolic (FV~d~), mean (FV~m~), and systolic (FV~s~) middle cerebral artery flow velocities, FV~d~, FV~m~, and FV~s~ straight sinus flow velocities were recorded by 2 MHz linear probes (GE Healthcare, Beijing, China) on the straight sinus through an occipital and transforaminal bone window \[[@CR5]\].

Optic nerve sheath diameter measurements {#Sec9}
----------------------------------------

Optic nerve sheath diameter was recorded by 7.5 MHz linear probes (GE Healthcare, Beijing, China) with the lowest possible acoustic power. The gel was applied on the surface of eyelids. The probe was oriented 30^0^ on both closed eyes of the patients with the head elevated to 30^0^ in the supine position at approximately 30^0^ on the length of the plane and at the horizontal surface. The measurements of axial and sagittal planes of both eyes had been made such that the visible widest diameter behind the retina was 2.8 mm (Fig. [1](#Fig1){ref-type="fig"}) \[[@CR13]\].Fig. 1Ultrasound measurements of the axial plane of the right eye. **a** Optic nerve sheath of a patient with normal intracranial pressure. No subarachnoid space around the optic nerve. **b** Optic nerve sheath of a patient with high intracranial pressure. Significant subarachnoid space around the optic nerve

Arterial transcranial Doppler measurement {#Sec10}
-----------------------------------------

2 MHz linear probe (GE Healthcare, Beijing, China) was used to measure arterial transcranial Doppler measurement in the same supine position of the patients. It was performed bilaterally on middle cerebral artery using temporal window \[[@CR14]\].

Events of mortality were collected from institutional records.

Statistical analysis {#Sec11}
--------------------

InStat GraphPad Software, San Diego, IL, USA was used for statistical analysis. Pearson correlation was tested for diagnostic parameters. Logistical regression analysis was performed for diagnostic parameters among the data of death patients. Inter-rater reliability was evaluated by intraclass correlation coefficient (\> 0.8: optimal, 0.7--0.8: strong, 0.5--0.69: moderate, 0.3--0.49: fair, \< 0.3: poor), calculated by a two-way random effects model in Stata 12.1 software (StataCorp, College Station, TX, USA) \[[@CR15]\]. The results were considered significant at 95% of confidence level.

Results {#Sec12}
=======

Enrollment {#Sec13}
----------

Data of patients who required intracranial pressure monitoring or mechanical ventilation with an admission diagnosis from 12 February 2017 to 1 January 2019 of the Beijing Luhe Hospital, Affiliated to Capital Medical University, Beijing, China, and referring hospitals were reviewed. Among the available patients' records, 15 patients had optic nerve injuries, 41 had skull base fracture, 13 had a known history of ocular pathology, 40 had inaccessible ultrasound windows, 11 had no radiological susceptibility of cerebral venous thrombosis, and 12 had no clinical susceptibility of cerebral thrombosis. Therefore, these data were excluded from the analysis. Also, 8 patients were on treatment that might affect cerebrospinal fluid pressure, so excluded from the analysis. Even, 15 patients had reported more than ±2 mmHg changes in mean values of intracranial pressure during ultrasound measurements. Therefore, these data were also excluded from the analysis. Data of invasive intracranial pressure measurement method and ultrasound measurements of 185 patients were included in the analysis. Flow chart of the study is presented in Fig. [2](#Fig2){ref-type="fig"}.Fig. 2Flowchart of the analysis

Characteristics of patients {#Sec14}
---------------------------

The minimum admission Glasgow Coma Scale of the enrolled patients was 4. The other demographical and clinical characteristics of enrolled patients are presented in Table [1](#Tab1){ref-type="table"}.Table 1Demographical and clinical characteristics of enrolled patientsCharacteristicsValueData of patients included in the analysis185GenderMale86 (47)Female99 (53)Age (years)Minimum38Maximum68Mean ± SD52.42 ± 4.53Weight (kg)58.42 ± 4.59Height (cm)161 ± 6Pathology Traumatic brain injury135 (73) Intraparenchymal hemorrhage38 (21) Aneurysmal subarachnoid hemorrhage12 (6)Comorbidities Asthma19 (10) Hypertension18 (10) Depression35 (19) Alcoholic8 (4) Smokers15 (8) History of myocardial infarction3 (2) Admission Glasgow Coma ScaleMaximum14Minimum4Median9 Discharge Glasgow Outcome ScaleMaximum5Minimum1Median3 Chest infection29 (16) Post-traumatic acute respiratory distress syndrome6 (3) Sepsis5 (3) Ventriculitis2 (1)Categorial variables are represented as number (percentage) and continuous variables are represented as mean ± SD or median

Diagnostic parameters {#Sec15}
---------------------

Straight sinus flow velocities, middle cerebral artery flow velocities, and optic nerve sheath diameter were correlated with intracranial pressure (*p* \< 0.0001 for all). Arterial blood pressure (*p* = 0.127) and middle cerebral artery pulsatility index (*p* = 0.06) were not correlated with intracranial pressure (Table [2](#Tab2){ref-type="table"}). Inter-rater reliability had strong agreement (intraclass correlation coefficient = 0.71) among ultra-sonographers.Table 2Diagnostic parametersCharacteristicsValuer (Pearson correlation coefficient)Significant range of 'r'*p*-valueData of patients included in the analysis185Intracranial pressure (mmHg)Minimum5ReferenceReferenceReferenceMaximum17Mean ± SD10.24 ± 3.51^a^Arterial blood pressure (mmHg)Minimum840.11250.2527--0.32330.127Maximum101Mean ± SD90.61 ± 5.29Cerebral perfusion pressure (mmHg)Minimum710.95270.9243--0.957\< 0.0001Maximum88Mean ± SD78.13 ± 4.58Partial pressure of carbon dioxide (mmHg)Minimum4.850.90270.872--0.9264\< 0.0001Maximum5.95Mean ± SD5.24 ± 0.27Straight sinus systolic flow velocity (cm/s)Minimum230.86620.825--0.8982\< 0.0001Maximum40Mean ± SD31.11 ± 4.9Straight sinus diastolic flow velocity (cm/s)Minimum120.55380.4451--0.6465\< 0.0001Maximum18Mean ± SD13.47 ± 1.31Straight sinus means flow velocity (cm/s)Minimum150.92980.9072--0.947\< 0.0001Maximum25Mean ± SD20.16 ± 3.23Middle cerebral artery systolic flow velocity (cm/s)Minimum950.87240.833--0.9031\< 0.0001Maximum115Mean ± SD103.27 ± 5.64Middle cerebral artery diastolic flow velocity (cm/s)Minimum400.76810.7016--0.8214\< 0.0001Maximum55Mean ± SD47.38 ± 4.26Middle cerebral artery means flow velocity (cm/s)Minimum600.90.8685--0.9243\< 0.0001Maximum76Mean ± SD69.1 ± 3.81Optic nerve sheath diameter (mm)Minimum40.87170.832--0.9025\< 0.0001Maximum6Mean ± SD4.77 ± 0.43^a^Middle cerebral artery pulsatility indexMinimum0.850.14230.2134--0.28090.06Maximum1.05Mean ± SD0.93 ± 0.08Variables are represented as mean ± SDPearson correlation was performed with intracranial pressureA *p* value less than 0.05 was considered significant^a^Insignificant correlation with intracranial pressure

Prediction of mortality {#Sec16}
-----------------------

From institutional records, it was found that 34 patients died during hospitalization and 13 patients died during the follow-up period. No significant association was observed between intracranial pressure and neuropsychological and functional outcomes during hospitalization and follow-up period for survived patients. Multivariate analysis was performed among diagnostic data of death patients. Intracranial pressure (*p* = 0.015) and optic nerve sheath diameter (*p* = 0.035) were found to be independent predictor of mortality (Table [3](#Tab3){ref-type="table"}).Table 3Multivariate analysis for prediction of mortalityCharacteristics*p*-valueData of patients included in the analysis47Intracranial pressure^a^0.015Arterial blood pressure0.12Cerebral perfusion pressure0.072Partial pressure of carbon dioxide0.085Straight sinus systolic flow velocity0.062Straight sinus diastolic flow velocity0.067Straight sinus means flow velocity0.068Middle cerebral artery systolic flow velocity0.078Middle cerebral artery diastolic flow velocity0.086Middle cerebral artery means flow velocity0.082Optic nerve sheath diameter^a^0.035Middle cerebral artery pulsatility index0.095A *p* value less than 0.05 was considered significantData of survived patients were considered as the reference standard^a^Significant predictor of mortality

Discussion {#Sec17}
==========

Intracranial pressure measurement {#Sec18}
---------------------------------

In the study, all the enrolled patients required admission diagnosis and subjected to measure intracranial pressure. Also, elevated intracranial pressure was found a significant parameter of death (*p* = 0.015) and no association between intracranial pressure and neuropsychological outcome during follow-up period among survivors. The results of the study were consistent with prospective cohort studies \[[@CR1], [@CR5]\] and a multicenter, controlled trial \[[@CR2]\]. The pathophysiological events and elevated intracranial pressure can have effects on neuropsychological outcome in patients with brain injury \[[@CR16]\]. Intracranial pressure is an independent predictor of death in patients with brain injury.

Venous transcranial Doppler measurements {#Sec19}
----------------------------------------

Straight sinus flow velocities and middle cerebral artery flow velocities had a correlation with intracranial pressure, those were measured invasively but failed to predict mortality. The results of the study were consistent with the clinical study \[[@CR2], [@CR17]\] and with prospective observational study \[[@CR5]\]. Increasing intracranial pressure leads to venous hemodynamic changes but strongly in the low-pressure venous compartment only \[[@CR5]\]. Transcranial insonation difficulties and anatomical variations in cerebral veins were responsible for the poor performance of straight sinus and middle cerebral artery flow velocities to predict intracranial pressure \[[@CR5]\]. Venous transcranial Doppler measurements are poorly developed method of diagnosis.

Optic nerve sheath diameter measurements {#Sec20}
----------------------------------------

Optic nerve sheath diameter was found an individual parameter of death (*p* = 0.035) as well as had correlation (*p* \< 0.0001) with intracranial pressure, those were measured invasively. The results of the study were consistent with prospective observational studies \[[@CR5], [@CR7], [@CR9], [@CR18]\] and a multicenter, controlled trial \[[@CR2]\]. The optic nerve is surrounded by cerebrospinal fluid \[[@CR7]\]. If cerebrospinal fluid pressure increases, there will be enlargement of the optic nerve sheath \[[@CR5]\]. Even, measurement of optic nerve sheath diameter is a simple, accurate, safe, and quick method of diagnosis. Clinicians would prefer the measurements of optic nerve sheath diameter in their intensive care units for patients with brain injury.

Arterial transcranial doppler measurement {#Sec21}
-----------------------------------------

Middle cerebral artery pulsatility index had no correlation (*p* = 0.06) with intracranial pressure and was not independent parameter of death (*p* = 0.095). The results of the study were consistent with the clinical studies \[[@CR5], [@CR17]\] but not consistent with case report \[[@CR19]\]. The possible justification is that in physiological parameters may affect pulsatility index \[[@CR17]\] while intracranial pressure is independent parameter \[[@CR20]\]. Even, intracranial pressure is a dynamic dimension that changes rapidly with time \[[@CR7]\] and it is unclear whether or how pulsatility index would change. Pulsatility index is not a reliable predictor of intracranial pressure.

Ultrasound versus invasive intracranial pressure measurement {#Sec22}
------------------------------------------------------------

During the study, besides the invasive intracranial pressure measurement method, optic nerve sheath diameter and arterial and venous transcranial Doppler measurements were performed for all patients who required measurements of intracranial pressure. Invasive intracranial pressure measurement devices are 'gold standard' modalities \[[@CR21]\] but due to the lack of neurosurgeons and/or contraindications, it is not always feasible \[[@CR5], [@CR19]\]. Arterial and venous transcranial ultrasound is fast and does not require specific dedicated hardware \[[@CR8]\]. Ultrasonography device is available in the intensive care unit too \[[@CR5]\]. Ultrasonography equipment is a hands-free tool for patients who need to measure intracranial pressure.

Limitations {#Sec23}
-----------

Several limitations of the study have reported for examples, different types of brain injury patients were enrolled. Type of brain injury also has an effect on mortality. Effects of type of brain injury on mortality is not evaluated in multivariate analysis. There is a need for specialized training for image analysis of ultrasound. The threshold values for intracranial pressure and optic nerve sheath diameter are not well-defined for brain injuries \[[@CR5]\]. Unlike an invasive method, ultra-sound has inter-and intra-observer variabilities.

Conclusion {#Sec24}
==========

Non-invasively measured straight sinus flow velocities, middle cerebral artery flow velocities, and optic nerve sheath diameter were correlated with invasively measured intracranial pressure. Optic nerve sheath diameter and intracranial pressure were independent parameters for mortality. Ultrasound measurement can be successfully used instead of invasive intracranial pressure measurement method in patients with brain injury. The large human trial is recommended to validate non-invasive techniques.
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